Glen Eagle Advisors, LLC Lantheus Holdings, Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 433 shares of LNTH stock, worth $44,157. This represents 0.01% of its overall portfolio holdings.
Number of Shares
433Holding current value
$44,157% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding LNTH
# of Institutions
494Shares Held
67.2MCall Options Held
1.19MPut Options Held
829K-
Black Rock Inc. New York, NY8.6MShares$877 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.57MShares$772 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$340 Million0.15% of portfolio
-
State Street Corp Boston, MA2.49MShares$254 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.28MShares$232 Million0.89% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $7.01B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...